226 related articles for article (PubMed ID: 10651760)
1. Leptin concentrations in Prader-Willi syndrome before and after growth hormone replacement.
Myers SE; Davis A; Whitman BY; Santiago JV; Landt M
Clin Endocrinol (Oxf); 2000 Jan; 52(1):101-5. PubMed ID: 10651760
[TBL] [Abstract][Full Text] [Related]
2. Endocrine and metabolic aspects of adult Prader-Willi syndrome with special emphasis on the effect of growth hormone treatment.
Höybye C
Growth Horm IGF Res; 2004 Feb; 14(1):1-15. PubMed ID: 14700552
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone treatment downregulates serum leptin levels in children independent of changes in body mass index.
Elimam A; Lindgren AC; Norgren S; Kamel A; Skwirut C; Bang P; Marcus C
Horm Res; 1999; 52(2):66-72. PubMed ID: 10681635
[TBL] [Abstract][Full Text] [Related]
4. Carbohydrate metabolism is not impaired after 3 years of growth hormone therapy in children with Prader-Willi syndrome.
L'Allemand D; Eiholzer U; Schlumpf M; Torresani T; Girard J
Horm Res; 2003; 59(5):239-48. PubMed ID: 12714788
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone improves body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome: A controlled study.
Carrel AL; Myers SE; Whitman BY; Allen DB
J Pediatr; 1999 Feb; 134(2):215-21. PubMed ID: 9931532
[TBL] [Abstract][Full Text] [Related]
6. Benefits of long-term GH therapy in Prader-Willi syndrome: a 4-year study.
Carrel AL; Myers SE; Whitman BY; Allen DB
J Clin Endocrinol Metab; 2002 Apr; 87(4):1581-5. PubMed ID: 11932286
[TBL] [Abstract][Full Text] [Related]
7. Interrelationship between insulin, leptin and growth hormone in growth hormone-treated children.
Zadik Z; Wittenberg I; Segal N; Altman Y; Zung A; Gross V; Reifen R
Int J Obes Relat Metab Disord; 2001 Apr; 25(4):538-42. PubMed ID: 11319659
[TBL] [Abstract][Full Text] [Related]
8. Sustained benefit after 2 years of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome.
Myers SE; Carrel AL; Whitman BY; Allen DB
J Pediatr; 2000 Jul; 137(1):42-9. PubMed ID: 10891820
[TBL] [Abstract][Full Text] [Related]
9. Sustained benefits of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome are dose-dependent.
Carrel AL; Myers SE; Whitman BY; Allen DB
J Pediatr Endocrinol Metab; 2001; 14(8):1097-105. PubMed ID: 11592566
[TBL] [Abstract][Full Text] [Related]
10. Circulating Levels of Nesfatin-1 and Spexin in Children with Prader-Willi Syndrome during Growth Hormone Treatment and Dietary Intervention.
Gajewska J; Szamotulska K; Klemarczyk W; Chełchowska M; Strucińska M; Ambroszkiewicz J
Nutrients; 2023 Mar; 15(5):. PubMed ID: 36904239
[TBL] [Abstract][Full Text] [Related]
11. Adiponectin levels in prepubertal children with Prader-Willi syndrome before and during growth hormone therapy.
Festen DA; van Toorenenbergen A; Duivenvoorden HJ; Hokken-Koelega AC
J Clin Endocrinol Metab; 2007 Apr; 92(4):1549-54. PubMed ID: 17264186
[TBL] [Abstract][Full Text] [Related]
12. Metabolic profiling in Prader-Willi syndrome and nonsyndromic obesity: sex differences and the role of growth hormone.
Irizarry KA; Bain J; Butler MG; Ilkayeva O; Muehlbauer M; Haqq AM; Freemark M
Clin Endocrinol (Oxf); 2015 Dec; 83(6):797-805. PubMed ID: 25736874
[TBL] [Abstract][Full Text] [Related]
13. The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study.
Whitman BY; Myers S; Carrel A; Allen D
Pediatrics; 2002 Feb; 109(2):E35. PubMed ID: 11826245
[TBL] [Abstract][Full Text] [Related]
14. Resting metabolic rate, plasma leptin concentrations, leptin receptor expression, and adipose tissue measured by whole-body magnetic resonance imaging in women with Prader-Willi syndrome.
Goldstone AP; Brynes AE; Thomas EL; Bell JD; Frost G; Holland A; Ghatei MA; Bloom SR
Am J Clin Nutr; 2002 Mar; 75(3):468-75. PubMed ID: 11864851
[TBL] [Abstract][Full Text] [Related]
15. Characterization of fat distribution in Prader-Willi syndrome: relationships with adipocytokines and influence of growth hormone treatment.
Tanaka Y; Abe Y; Oto Y; Itabashi H; Shiraishi M; Yoshino A; Obata K; Murakami N; Nagai T
Am J Med Genet A; 2013 Jan; 161A(1):27-33. PubMed ID: 23239671
[TBL] [Abstract][Full Text] [Related]
16. Circulating ghrelin levels are suppressed by meals and octreotide therapy in children with Prader-Willi syndrome.
Haqq AM; Stadler DD; Rosenfeld RG; Pratt KL; Weigle DS; Frayo RS; LaFranchi SH; Cummings DE; Purnell JQ
J Clin Endocrinol Metab; 2003 Aug; 88(8):3573-6. PubMed ID: 12915638
[TBL] [Abstract][Full Text] [Related]
17. Increased adrenal androgen levels in patients with Prader-Willi syndrome are associated with insulin, IGF-I, and leptin, but not with measures of obesity.
L'Allemand D; Eiholzer U; Rousson V; Girard J; Blum W; Torresani T; Gasser T
Horm Res; 2002; 58(5):215-22. PubMed ID: 12401940
[TBL] [Abstract][Full Text] [Related]
18. Peptides associated with hyperphagia in adults with Prader-Willi syndrome before and during GH treatment.
Höybye C; Barkeling B; Espelund U; Petersson M; Thorén M
Growth Horm IGF Res; 2003 Dec; 13(6):322-7. PubMed ID: 14624765
[TBL] [Abstract][Full Text] [Related]
19. Prader-Willi syndrome: how does growth hormone affect body composition and physical function?
Carrel AL; Allen DB
J Pediatr Endocrinol Metab; 2001; 14 Suppl 6():1445-51. PubMed ID: 11837498
[TBL] [Abstract][Full Text] [Related]
20. Serum leptin concentrations in children with Prader-Willi syndrome and non-syndromal obesity.
Bueno G; Moreno LA; Pineda I; Campos J; Ruibal JL; Juste MG; Casado E; Bueno M
J Pediatr Endocrinol Metab; 2000 Apr; 13(4):425-30. PubMed ID: 10776997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
